ESC 365 - ACR and lipid point-of-care testing as tools for CVD prediction and management.

Open Access

ACR and lipid point-of-care testing as tools for CVD prediction and management.

Session: Prevention of cardiovascular diseases in the post-COVID19 era

Topic: Prevention

Speaker: Professor O. Schnell (Munich, DE)

Sponsored by Abbott

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Oliver Schnell

Sciarc GmbH, Munich (Germany)

3 presentations

0 follower

3 more presentations in this session

Welcome and introduction.

Speaker: Professor W. Koenig (Munich, DE)

The burden of CV disease and the value of cardiac biomarkers in the post-COVID19 era.

Speaker: Professor N. Sattar (Glasgow, GB)

Setting troponin as a key risk stratification tool in CVD prevention: practical recommendations.

Speaker: Associate Professor D. Farmakis (Athens, GR)

Access the full session

Prevention of cardiovascular diseases in the post-COVID19 era

Speakers: Professor O. Schnell, Professor W. Koenig, Professor N. Sattar, Associate Professor D. Farmakis

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources